HUMA
Humacyte Inc.
$1.67
+$0.05(+3.09%)
29
Overall
40
Value
18
Tech
--
Quality
Market Cap
$294.57M
Volume
3.26M
52W Range
$1.15 - $6.77
Target Price
$8.29
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | $1.5M | $1.3M | $1.6M | -- | -- | ||
| Total Revenue | $1.5M | $1.3M | $1.6M | -- | -- | ||
| GROSS PROFIT | |||||||
| Gross Profit | $1.5M | $1.3M | $1.6M | -- | -- | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $66.1M | $82.5M | $84.6M | $100.0M | $114.4M | ||
| Research & Development | $54.1M | $61.3M | $63.3M | $76.5M | $88.6M | ||
| Research Expense | $54.1M | $61.3M | $63.3M | $76.5M | $88.6M | ||
| Selling, General & Administrative | $12.0M | $21.1M | $22.9M | $23.5M | $25.8M | ||
| General & Administrative Expenses | $12.0M | $21.1M | $22.9M | $23.5M | $25.8M | ||
| Salaries & Wages | -- | -- | -- | $6.8M | $6.1M | ||
| Depreciation & Amortization | $6.3M | $6.2M | $6.2M | $5.7M | $5.1M | ||
| Depreciation & Amortization | $6.3M | $6.2M | $6.2M | $5.7M | $5.1M | ||
| Amortization | $2.1M | $2.1M | $2.1M | $2.1M | $2.1M | ||
| Other Operating Expenses | $4.4M | $4.2M | $4.1M | $3.9M | $3.7M | ||
| OPERATING INCOME | |||||||
| Operating income | $-64.6M | $-81.2M | $-84.6M | $-100.0M | $-114.4M | ||
| EBITDA | $-56.0M | $-13.9M | $2.4M | $-102.9M | $-142.3M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $2.2M | $4.3M | $6.2M | $1.7M | $1.5M | ||
| Intinc | $278.0K | $16.0K | $2.6M | $5.5M | $4.1M | ||
| Net Non-Operating Interest Income/Expense | $-1.9M | $-4.3M | $-3.6M | $5.5M | $4.1M | ||
| Gain on Sale of Securities | -- | -- | $417.0K | $-260.0K | $3.9M | ||
| Other Income/Expense | $-1.5M | $-60.3M | $76.2M | $12.7M | $29.1M | ||
| Other Special Charges | $1.5M | $4.6M | $1.6M | $-2.4M | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-64.3M | $-22.1M | $-5.8M | $-111.1M | $-149.6M | ||
| Pre-Tax Income | $-66.5M | $-26.5M | $-12.0M | $-107.3M | $-139.4M | ||
| INCOME TAX | |||||||
| Tax Provision | $-1.7M | $-1.7M | $-1.8M | $-2.1M | $-2.4M | ||
| NET INCOME | |||||||
| Net Income | $-66.5M | $-26.5M | $-12.0M | $-110.8M | $-148.7M | ||
| Net Income (Continuing Operations) | $-66.5M | $-26.5M | $-12.0M | $-110.8M | $-148.7M | ||
| Net Income (Discontinued Operations) | $-66.5M | $-26.5M | $-12.0M | $-110.8M | $-148.7M | ||
| Net Income (Common Stockholders) | $-66.5M | $-26.5M | $-12.0M | $-110.8M | $-148.7M | ||
| Normalized Income | -- | -- | -- | -- | $-108.8M | ||
| TOTALS | |||||||
| Total Expenses | $66.1M | $82.5M | $84.6M | $100.0M | $114.4M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $5.8M | $40.0M | $103.1M | $103.4M | $118.5M | ||
| Average Shares Outstanding (Diluted) | $5.8M | $40.0M | $103.1M | $103.4M | $118.5M | ||
| Shares Outstanding | $12.9M | $103.0M | $103.3M | $119.1M | $155.1M | ||
| Basic EPS | $-11.54 | $-0.66 | $-0.12 | $-1.07 | $-1.26 | ||
| Basic EPS (Continuing Operations) | $-11.54 | $-0.66 | $-0.12 | $-1.07 | $-1.26 | ||
| Diluted EPS | $-11.54 | $-0.66 | $-0.12 | $-1.07 | $-1.26 | ||
| Diluted EPS (Continuing Operations) | $-11.54 | $-0.66 | $-0.12 | $-1.07 | $-1.26 | ||
| OTHER METRICS | |||||||
| Other Gand A | $12.0M | $21.1M | $22.9M | $23.5M | $25.8M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HUMA | $1.67 | +3.1% | 3.26M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |